NAMSA Symposium Coming to China

In News by Kristi Posadny

Gaining access to the US or European (EU) medical device market can lead to many questions and concerns.  The US and EU Market are still two of largest medical device markets in the world, with regulations and testing requirements different from the China medical device market.

How is access gained? What testing needs to be done?  What are the clinical requirements?  These along with many more questions will be answered at the Biocompatibility and Performance of Medical Device Symposium in Shanghai China.

At BPMDS 2014 you will find industry experts, third party notified body reviewers, as well as health agencies and regulators providing in-depth coverage of relevant topics and numerous practical examples. They will also offer keen insight into these rapidly growing markets while promoting strong audience participation and ample time for active networking.

Learn from experts on the following topics:

  • FDA Regulations
  • CE Submissions
  • Clinical Trials in Europe and US
  • Why to conduct GLP Studies
  • Biocompatibility testing of medical devices
  • Packaging Validation
  • cGMP inspection
  • Materials Characterization

To learn more about this event, please visit BPMDS website.

Authors:

Kristi Posadny is the Marketing Event Coordinator at NAMSA, focusing on increasing NAMSA's visibility at events and bringing our knowledge to the medical device, regenerative medicine and combination device industry. She holds a BBA in Communication, Journalism and Related Programs from Miami University. Kristi has held various roles at NAMSA for nearly 10 years, in areas such as Chemistry, In Vivo and In Vitro Biocompatibility and now Marketing.